Riptac showed potential for efficacy and tolerability in prostate cancer patients who had received multiple prior lines of treatment, while Rybrevant offers a new opportunity in head and neck cancer. But Johnson & Johnson already trades at a premium valuation of 21 times expected 2027 earnings per share, limiting its relative upside in JPMorgan's view.
Foreign exchange effects and a higher share of low-margin businesses weighed on earnings, while lower expense ratios provided a partial cushion. Overseas orders grew by more than 50%, supporting Morgan Stanley’s decision to maintain its Overweight rating, but the profit quality of converted orders remains subject to product mix, exchange rates and costs.
The full phase three Pove results are consistent with prior disclosures, and Morgan Stanley remains positive on its combination of efficacy, safety and convenient dosing. The near-term focus shifts to the 30 November regulatory decision and payer coverage after launch; another kidney disease drug, inaxaplin, is due to report kidney function data in early 2027.
Large financing deals and demand for computing capacity continue to support AI expansion, but companies differ markedly in cash flow, contract structures and the conditions for bringing capacity online. Meanwhile, model usage is rising as providers cut prices to win customers.
Cresset Chief Investment Officer Mike Silverman speaks with Fox's *Barron's Roundtable*: He is not worried about inflation spiraling out of control, believes bond yields have peaked around 5%, and expects the Federal Reserve to keep raising rates to bring inflation down. He also discusses why divergent consumer experiences are key to understanding the current economy.
TeraWulf Chairman and CEO Paul Prager speaks with Fox's Claman's Power Players: the company signed a lease with Anthropic representing approximately 19 billion dollars in contracted revenue, of which the Kentucky project is a part; he also discusses how the real bottleneck for AI power demand lies in power and cooling infrastructure, not chips.
Stephanie Link, Hightower’s chief investment strategist, speaks with CNBC’s Squawk Box: during the busiest earnings week of the year, the period after volatility, combined with the settled election and a seasonally strong period, offers a window to add to positions amid volatility. She also discusses divergence in the cybersecurity sector and the example of Zscaler.
Bankless speaks with global liquidity expert Michael Howell: His assessment last year that liquidity growth had peaked and crypto was already in the late stage of the cycle was subsequently borne out. Now, Bitcoin’s 70 thousand dollar level is critical; whether it holds is a gauge of whether a liquidity turn has already appeared first in Bitcoin.
Prof G Markets hosts Scott Galloway and Ed Elson discuss how Musk merging one company into another often signals trouble for the former. They say Tesla is now the one in need of financial support, while SpaceX shareholders are the ones actually footing the bill. They also speculate that SpaceX could acquire Tesla as an indirect route into the S&P 500.
In this guest segment of Bloomberg’s The China Show, Jim Caron, chief investment officer of Morgan Stanley Investment Management’s Portfolio Solutions Group, discusses AI spending as the market’s current main theme, earnings expectations as high as 35% to 40%, and a potential pullback as a buying opportunity. The program also explains Moonshot’s latest Kimi K3.1 model, saying it trails top US models by only two or three points on several benchmarks and costs about half as much per task.
Billionaire investor Mark Cuban speaks with The Diary Of A CEO: AI itself does not understand consequences and has no ethics, while AI companies keep borrowing to expand computing capacity, borrowing more than they earn—a situation that could easily develop into a debt bubble. He also discusses his start in business selling garbage bags door to door as a child.
Groundwork Collaborative president Lindsay Owens speaks with Bloomberg’s Odd Lots: technology companies promise that AI agents will help consumers find the cheapest products, but price comparison in the digital age has itself become difficult because of pricing technology. She advocates imposing fiduciary duties on AI agents and examines the boundaries of algorithmic pricing through the history of price increases.
Former Federal Reserve Vice Chair Roger Ferguson speaks with CNBC’s “Squawk Box”: The Fed is more likely to hold steady this week, as the market also expects, but recent inflation readings have been disappointing and have not eased. He believes fighting inflation will require two more rate hikes, one in December and another after a period of observation.
Intismeran combined with Keytruda significantly improved recurrence-free survival after melanoma surgery, while early pancreatic cancer data provide mechanistic support for expansion into kidney cancer. But the wait for treatment to take effect, tissue sample requirements for manufacturing, and immature overall survival data still constrain the realization of the platform’s value.
Bernstein finds that, even after some trades have unwound, crowded long positions remain concentrated in semiconductors and networking equipment. The key distinction is which companies can deliver results sufficient to meet high expectations, and which less-crowded names face operating pressure or limits on the reliability of their scores.
Cailianshe’s midday market review shows that the market diverged after last Friday’s strong rebound, with pronounced selling pressure on tech stocks. Physical AI remains active, but the sector’s upside potential and the staying power of autonomous driving are key to judging whether the rally can continue.
New orders signed in the first three quarters rose 24.80% year on year, while revenue grew just 0.83% unemployment; third-quarter revenue rose 33.03% and losses narrowed. Operating improvement was evident in the single quarter, while the AI security strategy focuses mainly on existing security business scenarios.
AI films are entering cinemas, extending the industry's experiments from short-form content to the big screen. Securities firms expect improvements in production efficiency and content supply, while competition is also shifting toward high-quality IP, coordination across the production process, and delivery at scale.
Innovusion and Galbot are jointly developing perception systems for embodied robots, highlighting LiDAR’s continued expansion into robotics. Robots place greater emphasis on a wide field of view, high resolution and compact size; the opportunities for relevant companies depend on adapting solutions and deploying them in real-world applications.
